Treatment for Group A Streptococcal Infection
Penicillin or amoxicillin for 10 days is the first-line treatment for Group A streptococcal pharyngitis, based on proven efficacy, safety, narrow spectrum, and low cost. 1
First-Line Treatment (No Penicillin Allergy)
Oral therapy (choose one):
- Penicillin V:
- Children: 250 mg 2-3 times daily for 10 days
- Adolescents/adults: 250 mg 4 times daily OR 500 mg twice daily for 10 days
- Amoxicillin (often preferred in children due to better taste):
- 50 mg/kg once daily (max 1,000 mg) for 10 days, OR
- 25 mg/kg twice daily (max 500 mg per dose) for 10 days
Intramuscular option (for patients unlikely to complete oral therapy):
- Benzathine penicillin G: Single dose
- <60 lbs (27 kg): 600,000 units
- ≥60 lbs: 1,200,000 units
All these regimens carry strong recommendations with high-quality evidence 1. The choice between penicillin V and amoxicillin is primarily based on palatability—amoxicillin suspension tastes better for children 2.
Penicillin-Allergic Patients
For non-immediate hypersensitivity reactions:
- Cephalexin: 20 mg/kg/dose twice daily (max 500 mg/dose) for 10 days
- Cefadroxil: 30 mg/kg once daily (max 1 g) for 10 days
For immediate hypersensitivity (anaphylaxis) to β-lactams:
- Clindamycin: 7 mg/kg/dose three times daily (max 300 mg/dose) for 10 days
- Clarithromycin: 7.5 mg/kg/dose twice daily (max 250 mg/dose) for 10 days
- Azithromycin: 12 mg/kg once daily (max 500 mg) for 5 days
Critical Caveats
Avoid azithromycin when possible. While included in guidelines as an option for penicillin allergy, the most recent high-quality evidence shows azithromycin has inferior bacterial eradication rates (OR 0.53 for early eradication, 0.38 for late eradication compared to penicillin V), higher recurrence rates, and increased adverse events 3. Geographic resistance to macrolides varies and is well-documented 1.
Do not use cephalosporins in patients with immediate/anaphylactic penicillin allergy due to cross-reactivity risk 1.
Complete the full 10-day course (except azithromycin which is 5 days). This duration is necessary to achieve maximal pharyngeal eradication of Group A streptococcus and prevent rheumatic fever 1, 2. While some newer agents have been studied for shorter courses, definitive evidence supporting abbreviated therapy is insufficient 2.
Why Penicillin Remains First-Line
The evidence strongly supports penicillin/amoxicillin as first-choice therapy because:
- No resistance documented: Group A streptococcus has never developed penicillin resistance anywhere in the world 2
- Proven prevention of rheumatic fever: Benzathine penicillin G has demonstrated efficacy in preventing both primary and secondary rheumatic fever 2
- Narrow spectrum: Minimizes disruption of normal flora and reduces selection pressure for resistant organisms 1, 2
- Safety profile: Minimal adverse effects 1
- Cost-effective: Substantially less expensive than alternatives 1, 2
Recent network meta-analysis data from 2026 confirms that while some cephalosporins (cefdinir, cefpodoxime, cefprozil) show statistically superior eradication rates, standard penicillins should remain preferred first-line therapy to support antimicrobial stewardship 3.
Adjunctive Therapy
For symptom management:
- Acetaminophen or NSAIDs for moderate-to-severe symptoms or high fever
- Never use aspirin in children (Reye syndrome risk)
- Do not use corticosteroids for routine Group A streptococcal pharyngitis
Special Situations Not Requiring Treatment
Chronic carriers (recurrent pharyngitis with persistent positive tests but likely viral symptoms) generally do not need treatment unless specific high-risk circumstances exist: community outbreaks of rheumatic fever/invasive disease, personal/family history of rheumatic fever, or excessive anxiety 1.
Asymptomatic household contacts should not be routinely tested or treated 2, 4.